Description
A local research facility is seeking participants for a clinical research study on Treatment Resistant Depression. The purpose of this study is to see whether an investigational drug can be used to treat depression that has not responded to other antidepressant therapies. Many people who receive antidepressant treatment for their depression do not get an adequate response to the medicines they are taking. If someone has taken, or is currently taking, two or more antidepressants that are not working, this is sometimes referred to as treatment-resistant depression or TRD. The investigational drug in this study is a synthetic (man-made) form of psilocybin, also known as 'magic mushrooms'.
Your total participation in the study will last up to approximately 1 year with multiple follow-up appointments after your dosing session.
Reimbursement for reasonable, out-of-pocket expenses and travel may be available to qualified individuals.
Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.
Other focus groups:
